This report aims to provide a comprehensive presentation of the global market for CD133 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD133 Antibody. This report contains market size and forecasts of CD133 Antibody in global, including the following market information:
Global CD133 Antibody Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global CD133 Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polyclonal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CD133 Antibody include Abcam, Thermo Fisher Scientific, Proteintech, Cell Signaling Technology, BioLegend, Bioss, GeneTex, HUABIO and Miltenyi Biotec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CD133 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CD133 Antibody Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global CD133 Antibody Market Segment Percentages, by Type, 2022 (%)
Polyclonal
Monoclonal
Global CD133 Antibody Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global CD133 Antibody Market Segment Percentages, by Application, 2022 (%)
Enzyme Linked Immunosorbent Assay
Immunocytochemistry
Immunohistochemistry
Western Blot
Others
Global CD133 Antibody Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global CD133 Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CD133 Antibody revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CD133 Antibody revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
Thermo Fisher Scientific
Proteintech
Cell Signaling Technology
BioLegend
Bioss
GeneTex
HUABIO
Miltenyi Biotec
NSJ Bioreagents
United States Biological
Beckman Coulter
Boster Biological Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of CD133 Antibody, market overview.
Chapter 2: Global CD133 Antibody market size in revenue.
Chapter 3: Detailed analysis of CD133 Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CD133 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CD133 Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD133 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CD133 Antibody Overall Market Size
2.1 Global CD133 Antibody Market Size: 2022 VS 2032
2.2 Global CD133 Antibody Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CD133 Antibody Players in Global Market
3.2 Top Global CD133 Antibody Companies Ranked by Revenue
3.3 Global CD133 Antibody Revenue by Companies
3.4 Top 3 and Top 5 CD133 Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies CD133 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 CD133 Antibody Players in Global Market
3.6.1 List of Global Tier 1 CD133 Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 CD133 Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CD133 Antibody Market Size Markets, 2022 & 2032
4.1.2 Polyclonal
4.1.3 Monoclonal
4.2 By Type - Global CD133 Antibody Revenue & Forecasts
4.2.1 By Type - Global CD133 Antibody Revenue, 2018-2023
4.2.2 By Type - Global CD133 Antibody Revenue, 2024-2032
4.2.3 By Type - Global CD133 Antibody Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CD133 Antibody Market Size, 2022 & 2032
5.1.2 Enzyme Linked Immunosorbent Assay
5.1.3 Immunocytochemistry
5.1.4 Immunohistochemistry
5.1.5 Western Blot
5.1.6 Others
5.2 By Application - Global CD133 Antibody Revenue & Forecasts
5.2.1 By Application - Global CD133 Antibody Revenue, 2018-2023
5.2.2 By Application - Global CD133 Antibody Revenue, 2024-2032
5.2.3 By Application - Global CD133 Antibody Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global CD133 Antibody Market Size, 2022 & 2032
6.2 By Region - Global CD133 Antibody Revenue & Forecasts
6.2.1 By Region - Global CD133 Antibody Revenue, 2018-2023
6.2.2 By Region - Global CD133 Antibody Revenue, 2024-2032
6.2.3 By Region - Global CD133 Antibody Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America CD133 Antibody Revenue, 2018-2032
6.3.2 US CD133 Antibody Market Size, 2018-2032
6.3.3 Canada CD133 Antibody Market Size, 2018-2032
6.3.4 Mexico CD133 Antibody Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe CD133 Antibody Revenue, 2018-2032
6.4.2 Germany CD133 Antibody Market Size, 2018-2032
6.4.3 France CD133 Antibody Market Size, 2018-2032
6.4.4 U.K. CD133 Antibody Market Size, 2018-2032
6.4.5 Italy CD133 Antibody Market Size, 2018-2032
6.4.6 Russia CD133 Antibody Market Size, 2018-2032
6.4.7 Nordic Countries CD133 Antibody Market Size, 2018-2032
6.4.8 Benelux CD133 Antibody Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia CD133 Antibody Revenue, 2018-2032
6.5.2 China CD133 Antibody Market Size, 2018-2032
6.5.3 Japan CD133 Antibody Market Size, 2018-2032
6.5.4 South Korea CD133 Antibody Market Size, 2018-2032
6.5.5 Southeast Asia CD133 Antibody Market Size, 2018-2032
6.5.6 India CD133 Antibody Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America CD133 Antibody Revenue, 2018-2032
6.6.2 Brazil CD133 Antibody Market Size, 2018-2032
6.6.3 Argentina CD133 Antibody Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CD133 Antibody Revenue, 2018-2032
6.7.2 Turkey CD133 Antibody Market Size, 2018-2032
6.7.3 Israel CD133 Antibody Market Size, 2018-2032
6.7.4 Saudi Arabia CD133 Antibody Market Size, 2018-2032
6.7.5 UAE CD133 Antibody Market Size, 2018-2032
7 CD133 Antibody Companies Profiles
7.1 Abcam
7.1.1 Abcam Company Summary
7.1.2 Abcam Business Overview
7.1.3 Abcam CD133 Antibody Major Product Offerings
7.1.4 Abcam CD133 Antibody Revenue in Global Market (2018-2023)
7.1.5 Abcam Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific CD133 Antibody Major Product Offerings
7.2.4 Thermo Fisher Scientific CD133 Antibody Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Proteintech
7.3.1 Proteintech Company Summary
7.3.2 Proteintech Business Overview
7.3.3 Proteintech CD133 Antibody Major Product Offerings
7.3.4 Proteintech CD133 Antibody Revenue in Global Market (2018-2023)
7.3.5 Proteintech Key News & Latest Developments
7.4 Cell Signaling Technology
7.4.1 Cell Signaling Technology Company Summary
7.4.2 Cell Signaling Technology Business Overview
7.4.3 Cell Signaling Technology CD133 Antibody Major Product Offerings
7.4.4 Cell Signaling Technology CD133 Antibody Revenue in Global Market (2018-2023)
7.4.5 Cell Signaling Technology Key News & Latest Developments
7.5 BioLegend
7.5.1 BioLegend Company Summary
7.5.2 BioLegend Business Overview
7.5.3 BioLegend CD133 Antibody Major Product Offerings
7.5.4 BioLegend CD133 Antibody Revenue in Global Market (2018-2023)
7.5.5 BioLegend Key News & Latest Developments
7.6 Bioss
7.6.1 Bioss Company Summary
7.6.2 Bioss Business Overview
7.6.3 Bioss CD133 Antibody Major Product Offerings
7.6.4 Bioss CD133 Antibody Revenue in Global Market (2018-2023)
7.6.5 Bioss Key News & Latest Developments
7.7 GeneTex
7.7.1 GeneTex Company Summary
7.7.2 GeneTex Business Overview
7.7.3 GeneTex CD133 Antibody Major Product Offerings
7.7.4 GeneTex CD133 Antibody Revenue in Global Market (2018-2023)
7.7.5 GeneTex Key News & Latest Developments
7.8 HUABIO
7.8.1 HUABIO Company Summary
7.8.2 HUABIO Business Overview
7.8.3 HUABIO CD133 Antibody Major Product Offerings
7.8.4 HUABIO CD133 Antibody Revenue in Global Market (2018-2023)
7.8.5 HUABIO Key News & Latest Developments
7.9 Miltenyi Biotec
7.9.1 Miltenyi Biotec Company Summary
7.9.2 Miltenyi Biotec Business Overview
7.9.3 Miltenyi Biotec CD133 Antibody Major Product Offerings
7.9.4 Miltenyi Biotec CD133 Antibody Revenue in Global Market (2018-2023)
7.9.5 Miltenyi Biotec Key News & Latest Developments
7.10 NSJ Bioreagents
7.10.1 NSJ Bioreagents Company Summary
7.10.2 NSJ Bioreagents Business Overview
7.10.3 NSJ Bioreagents CD133 Antibody Major Product Offerings
7.10.4 NSJ Bioreagents CD133 Antibody Revenue in Global Market (2018-2023)
7.10.5 NSJ Bioreagents Key News & Latest Developments
7.11 United States Biological
7.11.1 United States Biological Company Summary
7.11.2 United States Biological Business Overview
7.11.3 United States Biological CD133 Antibody Major Product Offerings
7.11.4 United States Biological CD133 Antibody Revenue in Global Market (2018-2023)
7.11.5 United States Biological Key News & Latest Developments
7.12 Beckman Coulter
7.12.1 Beckman Coulter Company Summary
7.12.2 Beckman Coulter Business Overview
7.12.3 Beckman Coulter CD133 Antibody Major Product Offerings
7.12.4 Beckman Coulter CD133 Antibody Revenue in Global Market (2018-2023)
7.12.5 Beckman Coulter Key News & Latest Developments
7.13 Boster Biological Technology
7.13.1 Boster Biological Technology Company Summary
7.13.2 Boster Biological Technology Business Overview
7.13.3 Boster Biological Technology CD133 Antibody Major Product Offerings
7.13.4 Boster Biological Technology CD133 Antibody Revenue in Global Market (2018-2023)
7.13.5 Boster Biological Technology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CD133 Antibody Market Opportunities & Trends in Global Market
Table 2. CD133 Antibody Market Drivers in Global Market
Table 3. CD133 Antibody Market Restraints in Global Market
Table 4. Key Players of CD133 Antibody in Global Market
Table 5. Top CD133 Antibody Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CD133 Antibody Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CD133 Antibody Revenue Share by Companies, 2018-2023
Table 8. Global Companies CD133 Antibody Product Type
Table 9. List of Global Tier 1 CD133 Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CD133 Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CD133 Antibody Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - CD133 Antibody Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CD133 Antibody Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global CD133 Antibody Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - CD133 Antibody Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CD133 Antibody Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global CD133 Antibody Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global CD133 Antibody Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CD133 Antibody Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America CD133 Antibody Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CD133 Antibody Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe CD133 Antibody Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CD133 Antibody Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia CD133 Antibody Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CD133 Antibody Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America CD133 Antibody Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CD133 Antibody Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa CD133 Antibody Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CD133 Antibody Revenue, (US$, Mn), 2024-2032
Table 30. Abcam Company Summary
Table 31. Abcam CD133 Antibody Product Offerings
Table 32. Abcam CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 33. Abcam Key News & Latest Developments
Table 34. Thermo Fisher Scientific Company Summary
Table 35. Thermo Fisher Scientific CD133 Antibody Product Offerings
Table 36. Thermo Fisher Scientific CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 37. Thermo Fisher Scientific Key News & Latest Developments
Table 38. Proteintech Company Summary
Table 39. Proteintech CD133 Antibody Product Offerings
Table 40. Proteintech CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 41. Proteintech Key News & Latest Developments
Table 42. Cell Signaling Technology Company Summary
Table 43. Cell Signaling Technology CD133 Antibody Product Offerings
Table 44. Cell Signaling Technology CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 45. Cell Signaling Technology Key News & Latest Developments
Table 46. BioLegend Company Summary
Table 47. BioLegend CD133 Antibody Product Offerings
Table 48. BioLegend CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 49. BioLegend Key News & Latest Developments
Table 50. Bioss Company Summary
Table 51. Bioss CD133 Antibody Product Offerings
Table 52. Bioss CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 53. Bioss Key News & Latest Developments
Table 54. GeneTex Company Summary
Table 55. GeneTex CD133 Antibody Product Offerings
Table 56. GeneTex CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 57. GeneTex Key News & Latest Developments
Table 58. HUABIO Company Summary
Table 59. HUABIO CD133 Antibody Product Offerings
Table 60. HUABIO CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 61. HUABIO Key News & Latest Developments
Table 62. Miltenyi Biotec Company Summary
Table 63. Miltenyi Biotec CD133 Antibody Product Offerings
Table 64. Miltenyi Biotec CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 65. Miltenyi Biotec Key News & Latest Developments
Table 66. NSJ Bioreagents Company Summary
Table 67. NSJ Bioreagents CD133 Antibody Product Offerings
Table 68. NSJ Bioreagents CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 69. NSJ Bioreagents Key News & Latest Developments
Table 70. United States Biological Company Summary
Table 71. United States Biological CD133 Antibody Product Offerings
Table 72. United States Biological CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 73. United States Biological Key News & Latest Developments
Table 74. Beckman Coulter Company Summary
Table 75. Beckman Coulter CD133 Antibody Product Offerings
Table 76. Beckman Coulter CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 77. Beckman Coulter Key News & Latest Developments
Table 78. Boster Biological Technology Company Summary
Table 79. Boster Biological Technology CD133 Antibody Product Offerings
Table 80. Boster Biological Technology CD133 Antibody Revenue (US$, Mn) & (2018-2023)
Table 81. Boster Biological Technology Key News & Latest Developments
List of Figures
Figure 1. CD133 Antibody Segment by Type in 2022
Figure 2. CD133 Antibody Segment by Application in 2022
Figure 3. Global CD133 Antibody Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CD133 Antibody Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global CD133 Antibody Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CD133 Antibody Revenue in 2022
Figure 8. By Type - Global CD133 Antibody Revenue Market Share, 2018-2032
Figure 9. By Application - Global CD133 Antibody Revenue Market Share, 2018-2032
Figure 10. By Type - Global CD133 Antibody Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global CD133 Antibody Revenue Market Share, 2018-2032
Figure 12. By Application - Global CD133 Antibody Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global CD133 Antibody Revenue Market Share, 2018-2032
Figure 14. By Region - Global CD133 Antibody Revenue Market Share, 2018-2032
Figure 15. By Country - North America CD133 Antibody Revenue Market Share, 2018-2032
Figure 16. US CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 17. Canada CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe CD133 Antibody Revenue Market Share, 2018-2032
Figure 20. Germany CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 21. France CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 23. Italy CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 24. Russia CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia CD133 Antibody Revenue Market Share, 2018-2032
Figure 28. China CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 29. Japan CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 32. India CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America CD133 Antibody Revenue Market Share, 2018-2032
Figure 34. Brazil CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa CD133 Antibody Revenue Market Share, 2018-2032
Figure 37. Turkey CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 38. Israel CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 40. UAE CD133 Antibody Revenue, (US$, Mn), 2018-2032
Figure 41. Abcam CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Thermo Fisher Scientific CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Proteintech CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cell Signaling Technology CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BioLegend CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bioss CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GeneTex CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. HUABIO CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Miltenyi Biotec CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. NSJ Bioreagents CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. United States Biological CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Beckman Coulter CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Boster Biological Technology CD133 Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
